Nutrición personalizada y síndrome metabólico
NUPERMET
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (4)
2019
-
A Randomized, Double-Blind, Placebo-Controlled Study of Gelesis100: A Novel Nonsystemic Oral Hydrogel for Weight Loss
Obesity, Vol. 27, Núm. 2, pp. 205-216
2017
-
Guide for current nutrigenetic, nutrigenomic, and nutriepigenetic approaches for precision nutrition involving the prevention and management of chronic diseases associated with obesity
Journal of Nutrigenetics and Nutrigenomics, Vol. 10, Núm. 1-2, pp. 43-62
2016
-
Guide and Position of the International Society of Nutrigenetics/Nutrigenomics on Personalised Nutrition: Part 1 - Fields of Precision Nutrition
Journal of Nutrigenetics and Nutrigenomics
1997
-
Actin-biding protein-280 binds the stress-activated protein kinase (SAPK) activator SEK-1 and is required for tumor necrosis factor-α activation of SAPK in melanoma cells
Journal of Biological Chemistry, Vol. 272, Núm. 5, pp. 2620-2628